These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8021749)

  • 1. Hydrophobic Zn(II)-naphthalocyanines as photodynamic therapy agents for Lewis lung carcinoma.
    Shopova M; Wohrle D; Stoichkova N; Milev A; Mantareva V; Muller S; Kassabov K; Georgiev K
    J Photochem Photobiol B; 1994 Apr; 23(1):35-42. PubMed ID: 8021749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposome-delivered Zn(II)-2,3-naphthalocyanines as potential sensitizers for PDT: synthesis, photochemical, pharmacokinetic and phototherapeutic studies.
    Wöhrle D; Shopova M; Müller S; Milev AD; Mantareva VN; Krastev KK
    J Photochem Photobiol B; 1993 Dec; 21(2-3):155-65. PubMed ID: 8301412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of delivery system on the pharmacokinetic and phototherapeutic properties of bis(methyloxyethyleneoxy) silicon-phthalocyanine in tumor-bearing mice.
    Wöhrle D; Muller S; Shopova M; Mantareva V; Spassova G; Vietri F; Ricchelli F; Jori G
    J Photochem Photobiol B; 1999 Jun; 50(2-3):124-8. PubMed ID: 10515076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetraamido-substituted 2,3-naphthalocyanine zinc(II) complexes as phototherapeutic agents: synthesis, comparative photochemical and photobiological studies.
    Müller S; Mantareva V; Stoichkova N; Kliesch H; Sobbi A; Wöhrle D; Shopova M
    J Photochem Photobiol B; 1996 Sep; 35(3):167-74. PubMed ID: 8933723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallo-naphthalocyanines as photothermal sensitisers for experimental tumours: in vitro and in vivo studies.
    Camerin M; Rello-Varona S; Villanueva A; Rodgers MA; Jori G
    Lasers Surg Med; 2009 Nov; 41(9):665-73. PubMed ID: 19790243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposome-delivered Si(IV)-naphthalocyanine as a photodynamic sensitiser for experimental tumours: pharmacokinetic and phototherapeutic studies.
    Cuomo V; Jori G; Rihter B; Kenney ME; Rodgers MA
    Br J Cancer; 1990 Dec; 62(6):966-70. PubMed ID: 2257228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of malignant melanoma by high-peak-power 1064 nm irradiation followed by photodynamic therapy.
    Busetti A; Soncin M; Jori G; Kenney ME; Rodgers MA
    Photochem Photobiol; 1998 Sep; 68(3):377-81. PubMed ID: 9747592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, tissue distribution and photodynamic therapy efficacy of liposomal-delivered hypocrellin A, a potential photosensitizer for tumor therapy.
    Wang ZJ; He YY; Huang CG; Huang JS; Huang YC; An JY; Gu Y; Jiang LJ
    Photochem Photobiol; 1999 Nov; 70(5):773-80. PubMed ID: 10568169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular density.
    Wang Y; Gonzalez M; Cheng C; Haouala A; Krueger T; Peters S; Decosterd LA; van den Bergh H; Perentes JY; Ris HB; Letovanec I; Debefve E
    Lasers Surg Med; 2012 Apr; 44(4):318-24. PubMed ID: 22362489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Si(IV)-methoxyethylene-glycol-naphthalocyanine: synthesis and pharmacokinetic and photosensitizing properties in different tumour models.
    Mantareva V; Shopova M; Spassova G; Wöhrle D; Muller S; Jori G; Ricchelli F
    J Photochem Photobiol B; 1997 Oct; 40(3):258-62. PubMed ID: 9372614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
    Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
    Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and photobiological study of a novel chlorin photosensitizer BCPD-18MA for photodynamic therapy.
    Zhang J; Deng L; Yao J; Gu P; Yang F; Wang X; Liu W; Zhang Y; Ke X; Jing X; Chen J
    Bioorg Med Chem; 2011 Sep; 19(18):5520-8. PubMed ID: 21855352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translating phototherapeutic indices from in vitro to in vivo photodynamic therapy with bacteriochlorins.
    Luz AFS; Pucelik B; Pereira MM; Dąbrowski JM; Arnaut LG
    Lasers Surg Med; 2018 Jul; 50(5):451-459. PubMed ID: 29714399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo photodynamic therapy with the new near-IR absorbing water soluble photosensitizer lutetium texaphyrin and a high intensity pulsed light delivery system.
    Kostenich G; Orenstein A; Roitman L; Malik Z; Ehrenberg B
    J Photochem Photobiol B; 1997 May; 39(1):36-42. PubMed ID: 9210320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of photosensitizer delivery system and irradiation parameters on the efficiency of photodynamic therapy of B16 pigmented melanoma in mice.
    Biolo R; Jori G; Soncin M; Rihter B; Kenney ME; Rodgers MA
    Photochem Photobiol; 1996 Feb; 63(2):224-8. PubMed ID: 8657736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency.
    Reddi E; Zhou C; Biolo R; Menegaldo E; Jori G
    Br J Cancer; 1990 Mar; 61(3):407-11. PubMed ID: 2328207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic therapy of B16F10 murine melanoma with lutetium texaphyrin.
    Woodburn KW; Fan Q; Kessel D; Luo Y; Young SW
    J Invest Dermatol; 1998 May; 110(5):746-51. PubMed ID: 9579539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel carbohydrate-substituted metallo-porphyrazine comparison for cancer tissue-type specificity during PDT.
    Horne TK; Cronjé MJ
    J Photochem Photobiol B; 2017 Aug; 173():412-422. PubMed ID: 28662468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice.
    Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H
    Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of a hydrophobic phthalocyanine photosensitizer using PEGylated gold nanoparticle conjugates for the in vivo photodynamic therapy of amelanotic melanoma.
    Camerin M; Moreno M; Marín MJ; Schofield CL; Chambrier I; Cook MJ; Coppellotti O; Jori G; Russell DA
    Photochem Photobiol Sci; 2016 May; 15(5):618-25. PubMed ID: 27064601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.